A randomized, controlled, phase II trial comparing escalating doses of subcutaneous interleukin-2 plus antiretrovirals versus antiretrovirals alone in human immunodeficiency virus-infected patients with CD4+ cell counts >/=350/mm3. (Q45742307)
Jump to navigation
Jump to search
scientific article published on 15 May 2000
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized, controlled, phase II trial comparing escalating doses of subcutaneous interleukin-2 plus antiretrovirals versus antiretrovirals alone in human immunodeficiency virus-infected patients with CD4+ cell counts >/=350/mm3. |
scientific article published on 15 May 2000 |
Statements
1 reference
A randomized, controlled, phase II trial comparing escalating doses of subcutaneous interleukin-2 plus antiretrovirals versus antiretrovirals alone in human immunodeficiency virus-infected patients with CD4+ cell counts >/=350/mm3. (English)
1 reference
Lane HC
1 reference
Losso MH
1 reference
Belloso WH
1 reference
Emery S
1 reference
Benetucci JA
1 reference
Cahn PE
1 reference
Lasala MC
1 reference
Lopardo G
1 reference
Salomon H
1 reference
Saracco M
1 reference
Nelson E
1 reference
Law MG
1 reference
Davey RT
1 reference
Allende MC
1 reference
15 May 2000
1 reference
1 reference
181
1 reference
1614-1621
1 reference
5
1 reference
Identifiers
1 reference
1 reference